2015 ASCO Journal Club: Breast Cancer Third Quarter

Each quarter, ASCO’s experts review the leading journals, including the Journal of Clinical Oncology, to compile the most relevant, practice-changing science in breast cancer. Reviews are presented in a didactic slide format, with audio commentary and links to references and resources and will focus on the following areas: translational science, clinical trials, reviews, guidelines, and editorials. 

Articles covered in this quarter’s review include:

  • Boughey J., Ballman K., Hunt K., et al.  Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).  J Clin Oncol.  2015: 1-7.  
  • Rugo H., Barry W., Alvaro A., et al.  Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab as First-Line Chemotherapy for Locally Recurrent of Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).  J Clin Oncol.  2015 8; 1-7. 
  • Warner E., Tamimi R., Hughes M., et al.  Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.  J Clin Oncol.  2015 July 10; 23(20): 2254-2261.

Learning Objectives
  • Determine the role of axillary ultrasound in optimizing management of the axilla in neoadjuvant setting
  • Describe how breast cancer tumor biology combined with race and ethnicity impacts breast cancer survival
  • Determine the optimal microtubule inhibitor, in combination with bevacizumab, for treatment naïve patients presenting with metastatic breast cancer
  • Apply knowledge learned to enhance the care delivered to patients with breast cancer.
Continuing Education Credit
1 Credit/Point is available for participation in this course. Certificate and credit types available include:
  • AMA PRA Category 1 Credits™  
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on September 30, 2018. Participants must complete all necessary course components by this date to receive credit.